Results 181 to 190 of about 1,080,358 (387)

A two-centre study investigating the association between brain natriuretic peptides & outcomes in continuous flow left ventricular assist device recipients

Journal of Cardiothoracic Surgery
Background Natriuretic peptides are useful prognostic markers in patients with heart failure and this study aims to evaluate the association between N-terminal pro-brain natriuretic peptide and outcomes in patients with a continuous-flow left ventricular
Maria Lambadaris, Farid Foroutan, Julie KK Vishram-Nielsen, Marie Sophie S. Knudsen, Filio Billia, Vivek Rao, Finn Gustafsson, Ana C Alba   +7 more
doaj   +1 more source

Role of Plasma B-type Natriuretic Peptide in Diagnosing Heart Failure

, 1970
Mohammed Saiful Alam, DHMS Sirajul Haque, Md Nurul Amin   +2 more
openalex   +2 more sources

Effects of antiserum against alpha-rat atrial natriuretic peptide in anesthetized rats. [PDF]

, 1987
Akira Sasaki, Osamu Kida, Johji Kato, Shigeru Nakamura, Kenji Kodama, Atsuro Miyata, Kenji Kangawa, H. Matsuo, Kenjiro Tanaka   +8 more
openalex   +1 more source

Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.

Journal of the American College of Cardiology, 2019
Nasrien E Ibrahim, Cian P. McCarthy, S. Shrestha, H. Gaggin, R. Mukai, J. Szymonifka, F. Apple, J. Burnett, Seethalakshmi R. Iyer, J. Januzzi   +9 more
semanticscholar   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Natriuretic peptide system and cardiovascular disease

Heart Views, 2010
The mammalian Natriuretic Peptide (NP) system consists of neuro-hormones, such as atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), c-type natriuretic peptide (CNP), and the N-Terminal fragment of BNP (NT-pro-BNP).
Federico Cacciapuoti
doaj  

Effects of atrial natriuretic peptide on transmural blood flow and reactive hyperemia in the presence of flow-limiting coronary stenosis in the awake dog: evidence for dilation of the intramural vasculature. [PDF]

, 1989
Alan Chu, A Stakely, Chang‐Chyi Lin, Frederick R. Cobb   +3 more
openalex   +1 more source

The natriuretic peptide family [PDF]

European Journal of Clinical Investigation, 1995
Garry McDowell, K. D. Buchanan, Christopher Shaw, D. P. Nicholls   +3 more
openaire   +2 more sources

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Atrial natriuretic peptide in the fetus. [PDF]

, 1989
John‏ Kingdom, Alan G. Jardine, Jackie Doyle, J. M. C. Connell, David Gilmore, Martin Whittle   +5 more
openalex   +1 more source